People · Operator

Dan Testa

Named in public records as an officer, director or promoter · active 2022–2022 · Other Technology

1
Companies
1
Filings
$36.0M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Advanced Solutions Holdings, Inc.Other TechnologySeries B$36.0M$17.9M2022
Operator network

Dan Testa at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Donald L. Hawks III · 2 companies · 1 sharedDonald L. Hawks I…Don Robertson · 2 companies · 1 sharedDon RobertsonJocelyn Y. Dyer · 2 companies · 1 sharedJocelyn Y. DyerRobert Alves · 2 companies · 1 sharedRobert AlvesDan S. Testa · 1 companies · 1 sharedDan S. TestaDon S. Robertson · 1 companies · 1 sharedDon S. RobertsonDoug Schoenberg · 1 companies · 1 sharedDoug SchoenbergGary J. Kinman · 1 companies · 1 sharedGary J. KinmanGary Y. Kinman · 1 companies · 1 sharedGary Y. KinmanJocelyn J. Dyer · 1 companies · 1 sharedJocelyn J. DyerMichael LaConti · 1 companies · 1 sharedMichael LaContiMichael L. LaConti · 1 companies · 1 sharedMichael L. LaContiRichard J. Davis · 1 companies · 1 sharedRichard J. DavisRobert S. Alves · 1 companies · 1 sharedRobert S. AlvesAdvanced Solutions Holdings, Inc. · $36.0M raisedAdvanced Solutions Ho…Dan TestaDT
Dan Testa Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Dan Testa on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Don Robertson12
Donald L. Hawks III12
Jocelyn Y. Dyer12
Robert Alves12
Michael LaConti11
Richard J. Davis11
Robert S. Alves11
Don S. Robertson11
Dan S. Testa11
Michael L. LaConti11
Gary Y. Kinman11
Jocelyn J. Dyer11
Doug Schoenberg11
Gary J. Kinman11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.